Mutation signature of patients with ER plus metastatic breast cancer who received endocrine therapy.

被引:0
作者
Ma, Fei
Zhang, Yan
Ouyang, Quchang
Dai, Pingping
Yi, Zongbi
Cao, Weiguo
Zhou, Yidong
Zhu, Chenchen
Guan, Yan-Fang
Yang, Ling
Yi, Xin
Xia, Xuefeng
机构
[1] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Geneplus Beijing Inst, Beijing, Changping, Peoples R China
[4] Hu Nan Tumor Hosp, Changsha, Peoples R China
[5] CAMS, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China
[6] PUMC, Beijing, Peoples R China
[7] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Radioat Oncol Dept, Shanghai, Peoples R China
[8] Peking Union Med Hosp, Beijing, Peoples R China
[9] Weill Cornell Sch Med, Houston Methodist Res Inst, Houston, TX USA
关键词
D O I
10.1200/JCO.2018.36.15_suppl.1057
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1057
引用
收藏
页数:1
相关论文
empty
未找到相关数据